McCombe William D. bought CTKB
August 18, 2026 · Form 4 insider transaction
McCombe William D. bought 6,320 shares of Cytek Biosciences, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,320
Price
N/A
Total value
N/A
InsiderMcCombe William D.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 18, 2026
Filing dateAugust 20, 2026
Shares owned after117,497
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.